224 related articles for article (PubMed ID: 32582572)
61. An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation.
Asavaroengchai W; Wang H; Wang S; Wang L; Bronson R; Sykes M; Yang YG
Biol Blood Marrow Transplant; 2007 Jan; 13(1):46-55. PubMed ID: 17222752
[TBL] [Abstract][Full Text] [Related]
62. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
[TBL] [Abstract][Full Text] [Related]
63. Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease.
Choi EY; Christianson GJ; Yoshimura Y; Jung N; Sproule TJ; Malarkannan S; Joyce S; Roopenian DC
Blood; 2002 Dec; 100(13):4259-65. PubMed ID: 12393464
[TBL] [Abstract][Full Text] [Related]
64. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection.
Munks MW; Pinto AK; Doom CM; Hill AB
J Immunol; 2007 Jun; 178(11):7235-41. PubMed ID: 17513772
[TBL] [Abstract][Full Text] [Related]
65. Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR.
Krawczyk A; Ackermann J; Goitowski B; Trenschel R; Ditschkowski M; Timm J; Ottinger H; Beelen DW; Grüner N; Fiedler M
J Clin Virol; 2018; 99-100():61-66. PubMed ID: 29331844
[TBL] [Abstract][Full Text] [Related]
66. CMV Triplex Vaccine to Enhance Adaptive NK and T-cell Reconstitution After Autologous Hematopoietic Cell Transplantation.
Rashidi A; La Rosa C; Curtsinger J; Cao Q; Zhou Q; Lingaraju CR; Weisdorf DJ; Cichocki F; Miller JS; Diamond DJ
Transplant Cell Ther; 2022 Jun; 28(6):343.e1-343.e4. PubMed ID: 35272066
[TBL] [Abstract][Full Text] [Related]
67. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
Fleming T; Dunne J; Crowley B
J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
[TBL] [Abstract][Full Text] [Related]
68. Hematopoietic cell-mediated dissemination of murine cytomegalovirus is regulated by NK cells and immune evasion.
Zhang S; Springer LE; Rao HZ; Espinosa Trethewy RG; Bishop LM; Hancock MH; Grey F; Snyder CM
PLoS Pathog; 2021 Jan; 17(1):e1009255. PubMed ID: 33508041
[TBL] [Abstract][Full Text] [Related]
69. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
Petersdorf EW; Hansen JA; Martin PJ; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C
N Engl J Med; 2001 Dec; 345(25):1794-800. PubMed ID: 11752355
[TBL] [Abstract][Full Text] [Related]
70. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
Front Immunol; 2018; 9():1129. PubMed ID: 29887865
[TBL] [Abstract][Full Text] [Related]
71. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
[TBL] [Abstract][Full Text] [Related]
72. Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.
Shenoy S; Desch K; Duffy B; Thorson P; Mohanakumar T
Clin Exp Immunol; 1998 May; 112(2):188-95. PubMed ID: 9649180
[TBL] [Abstract][Full Text] [Related]
73. Immune evasion proteins enhance cytomegalovirus latency in the lungs.
Böhm V; Seckert CK; Simon CO; Thomas D; Renzaho A; Gendig D; Holtappels R; Reddehase MJ
J Virol; 2009 Oct; 83(19):10293-8. PubMed ID: 19605491
[TBL] [Abstract][Full Text] [Related]
74. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells.
Ozdemir E; St John LS; Gillespie G; Rowland-Jones S; Champlin RE; Molldrem JJ; Komanduri KV
Blood; 2002 Nov; 100(10):3690-7. PubMed ID: 12393402
[TBL] [Abstract][Full Text] [Related]
75. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation.
Rufer N; Wolpert E; Helg C; Tiercy JM; Gratwohl A; Chapuis B; Jeannet M; Goulmy E; Roosnek E
Transplantation; 1998 Oct; 66(7):910-6. PubMed ID: 9798702
[TBL] [Abstract][Full Text] [Related]
76. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
Roback JD; Hossain MS; Lezhava L; Gorechlad JW; Alexander SA; Jaye DL; Mittelstaedt S; Talib S; Hearst JE; Hillyer CD; Waller EK
J Immunol; 2003 Dec; 171(11):6023-31. PubMed ID: 14634114
[TBL] [Abstract][Full Text] [Related]
77. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
Warren EH; Greenberg PD; Riddell SR
Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709
[TBL] [Abstract][Full Text] [Related]
78. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
79. Domestic and foreign donor candidates result in differential probability of matching minor histocompatibility antigens--relevance of selection for hematopoietic stem cell transplantation.
Turpeinen H; Volin L; Partanen J
Tissue Antigens; 2009 Mar; 73(3):236-41. PubMed ID: 19254253
[TBL] [Abstract][Full Text] [Related]
80. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]